FindTrial
Sign In

Lipidome and DNA Methylation for Understanding the Risk of Cardiovascular Disease in Women with Adverse Pregnancy Outcome

Establishment of Facility (Lipidome and DNA Methylation) Particularly for Understanding the Risk of Cardiovascular Disease in A Cohort of Women with Adverse Pregnancy Outcome - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/05/087084
Enrollment
200
Registered
2025-05-19
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Department of Biotechnology Government of India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Females who had preeclampsia during pregnancy will be followed up post pregnancy. Equal number of females who were normotensive during pregnancy will also be followed up.

Exclusion criteria

Exclusion criteria: Nil

Design outcomes

Primary

MeasureTime frame
Lipidome patterns (from maternal plasma and placentae) and DNA methylation patterns of genes involved in lipid metabolism in placentae of women with preeclampsia.Timepoint: At delivery—

Secondary

MeasureTime frame
Association of lipidome patterns during pregnancy and in later age (approx. 10-16 years post-delivery) and its association with cardiometabolic risk in women at later ageTimepoint: 10-16 years post pregnancy—

Countries

India

Contacts

Public ContactDr Sadhana Joshi

Interactive Research School for Health Affairs (IRSHA), (BVDU), Pune

sadhana.joshi@bharatividyapeeth.edu8007945167

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026